MedPath
TGA Approval

KEYTRUDA pembrolizumab (rch) 100mg/4 mL concentrated injection vial (263932)

263932

KEYTRUDA pembrolizumab (rch) 100mg/4 mL concentrated injection vial

Merck Sharp & Dohme (Australia) Pty Ltd

March 8, 2016

Medicine

Medicine

Active

Registered - Prescription Injectable

Product Information

Consumer Medicine Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2023-CMI-01513-1

Product Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2023-PI-01512-1

Active Ingredients

pembrolizumab

© Copyright 2025. All Rights Reserved by MedPath
KEYTRUDA pembrolizumab (rch) 100mg/4 mL concentrated injection vial (263932) - TGA 批准文号 | MedPath